![Side effect of fluoropyrimidine-based chemoRT for rectal cancer – Memorial Sloan Kettering Radiation Oncology](https://oncodaily.com/pub/uploads/2024/07/Memorial-Sloan-Kettering-Radiation-Oncology.png)
Photo taken from Memorial Sloan Kettering Radiation Oncology/X
Jul 13, 2024, 13:17
Side effect of fluoropyrimidine-based chemoRT for rectal cancer – Memorial Sloan Kettering Radiation Oncology
Memorial Sloan Kettering Radiation Oncology shared on X:
“This nurse-led multidisciplinary collaboration discusses a rare but (likely underreported) side effect of fluoropyrimidine-based chemoRT for rectal cancer, colorectal cancer. This is an important QOL issue often assumed to be a radiation toxicity but driven by capecitabine.”
Read further.
Source: Memorial Sloan Kettering Radiation Oncology/X
Jul 16, 2024, 05:18